Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, EClinicalMedicine, (60), p. 102025, 2023

DOI: 10.1016/j.eclinm.2023.102025

Links

Tools

Export citation

Search in Google Scholar

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

Journal article published in 2023 by Alexandra Compagnucci, Man K. Chan, Yacine Saïdi, Tim R. Cressey ORCID, Alasdair Bamford ORCID, Yoann Riault, Alexandra Coelho, Aoife Nolan, Suwalai Chalermpantmetagul, Gabija Morkunaite, Pauline Amuge, Victor Musiime, Avy Violari, Mark Cotton ORCID, Adeodata R. Kekitiinwa and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO